<DOC>
	<DOCNO>NCT01398449</DOCNO>
	<brief_summary>Is elective nodal irradiation ( ENI ) necessary patient thoracic esophageal cancer esophagectomy pathological stage T1-2 , N+ , M0 ?</brief_summary>
	<brief_title>Is ENI Necessary For Patients With Thoracic Esophageal Cancer After Esophagectomy And With Pathological Stage Of T1-2 , N+ , M0</brief_title>
	<detailed_description>Patient Population : Thoracic esophageal squamous cell carcinoma esophagectomy least 15 lymph node remove adequate nodal staging . R0 resection ; T1-2 , N+ , M0 . Scheme : After esophagectomy , patient firstly stratify number lymph node metastasis ( &lt; 3 &gt; =3 ) . Then patient randomize 2 arm : Arm A : Adjuvant chemotherapy ( 4 cycle ) . Arm B : Adjuvant chemotherapy ( 4 cycle ) + Elective Nodal Irradiation ( bilateral supraclavicular fossa mediastinum ) .</detailed_description>
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Carcinoma , Squamous Cell</mesh_term>
	<mesh_term>Esophageal Neoplasms</mesh_term>
	<criteria>1 . Age ≥ 18 ≤70 2 . ECOG performance status 01 3 . Weight le 90 % operation 4 . Registration within 8 week esophagectomy 5 . Histologically proven primary thoracic esophageal squamous cell carcinoma 6 . R0 resection number lymph node dissect ≥15 esophagectomy 7 . Stage T12N13M0 base pathological diagnosis 8 . Chest abdominal contrast enhance CT within 6 week prior registration ( PET/CT scan selective ) 9 . Without supraclavicular node abdominal region node exist surgery 10 . Without neoadjuvant chemotherapy radiotherapy 11 . WBC≥ 4.0X109/L , Absolute neutrophil count ( ANC ) ≥ 2.0X109/L 12 . Platelets ≥ 100X109/L 13 . Hemoglobin ≥ 90g/L ( without blood transfusion ) 14 . AST ( SGOT ) /ALT ( SGPT ) ≤ 2.5 x upper limit normal , Bilirubin ≤ 1.5 x upper limit normal 15 . Creatinine ≤ 1.5 x upper limit normal 16 . Sign studyspecific inform consent prior study entry 1 . Multiple primary esophageal tumor 2 . Prior invasive malignancy ( except nonmelanomatous skin cancer ) unless disease free minimum 2 year ( For example , carcinoma situ breast , oral cavity , cervix permissible ) . 3 . Severe , active comorbidity , define follow : 3.1 Unstable angina and/or congestive heart failure require hospitalization within last 3 month 3.2 Transmural myocardial infarction within last 6 month 3.3 Acute bacterial fungal infection require intravenous antibiotic time registration 3.4 Chronic obstructive pulmonary disease exacerbation respiratory illness require hospitalization preclude study therapy time registration 3.5 Acquired immune deficiency syndrome ( AIDS ) base upon current CDC definition ; note , however , HIV test require entry protocol . The need exclude patient AIDS protocol necessary treatment involve protocol may significantly immunosuppressive . 4 . Pregnancy woman childbearing potential men sexually active willing/able use medically acceptable form contraception . 5 . Prior systemic chemotherapy , prior radiation therapy prior target drug therapy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>March 2011</verification_date>
	<keyword>thoracic esophageal squamous cell carcinoma</keyword>
	<keyword>esophagectomy</keyword>
	<keyword>elective nodal irradiation</keyword>
	<keyword>adjuvant chemotherapy</keyword>
</DOC>